State Street Corp raised its position in Luminex Corporation (NASDAQ:LMNX) by 6.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,071,007 shares of the medical instruments supplier’s stock after acquiring an additional 61,218 shares during the quarter. State Street Corp owned 2.43% of Luminex Corporation worth $22,620,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the business. Voya Investment Management LLC grew its position in Luminex Corporation by 1.9% in the second quarter. Voya Investment Management LLC now owns 92,553 shares of the medical instruments supplier’s stock valued at $1,955,000 after acquiring an additional 1,737 shares in the last quarter. OxFORD Asset Management LLP grew its position in Luminex Corporation by 48.6% in the second quarter. OxFORD Asset Management LLP now owns 186,562 shares of the medical instruments supplier’s stock valued at $3,940,000 after acquiring an additional 61,047 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Luminex Corporation by 2.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,757,980 shares of the medical instruments supplier’s stock valued at $37,129,000 after acquiring an additional 39,094 shares in the last quarter. Citadel Advisors LLC grew its position in Luminex Corporation by 92.6% in the second quarter. Citadel Advisors LLC now owns 235,260 shares of the medical instruments supplier’s stock valued at $4,969,000 after acquiring an additional 113,139 shares in the last quarter. Finally, Renaissance Technologies LLC grew its position in shares of Luminex Corporation by 15.9% during the second quarter. Renaissance Technologies LLC now owns 1,841,540 shares of the medical instruments supplier’s stock worth $38,893,000 after buying an additional 252,299 shares in the last quarter. 76.84% of the stock is owned by institutional investors.

Shares of Luminex Corporation (LMNX) opened at $21.53 on Thursday. Luminex Corporation has a 1 year low of $17.68 and a 1 year high of $22.27. The firm has a market cap of $937.48, a P/E ratio of 36.69, a PEG ratio of 2.67 and a beta of 0.18.

Luminex Corporation (NASDAQ:LMNX) last announced its quarterly earnings data on Monday, October 30th. The medical instruments supplier reported $0.25 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.19 by $0.06. Luminex Corporation had a return on equity of 6.01% and a net margin of 9.52%. The firm had revenue of $74.14 million for the quarter, compared to analysts’ expectations of $74.38 million. During the same period last year, the business posted $0.21 earnings per share. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. research analysts anticipate that Luminex Corporation will post 0.49 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on LMNX shares. Zacks Investment Research raised shares of Luminex Corporation from a “hold” rating to a “strong-buy” rating and set a $22.00 price target for the company in a research report on Thursday, August 24th. Jefferies Group LLC reissued a “hold” rating and set a $21.00 price target on shares of Luminex Corporation in a research report on Friday, October 20th. BidaskClub downgraded shares of Luminex Corporation from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. TheStreet raised shares of Luminex Corporation from a “c+” rating to a “b-” rating in a research report on Wednesday, November 1st. Finally, ValuEngine raised shares of Luminex Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, September 6th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and one has given a strong buy rating to the company. Luminex Corporation currently has an average rating of “Hold” and a consensus target price of $20.00.

ILLEGAL ACTIVITY WARNING: “State Street Corp Purchases 61,218 Shares of Luminex Corporation (LMNX)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/11/16/state-street-corp-purchases-61218-shares-of-luminex-corporation-lmnx.html.

In related news, Director Robert J. Cresci sold 19,631 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $18.98, for a total transaction of $372,596.38. Following the transaction, the director now directly owns 260,358 shares in the company, valued at $4,941,594.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 6.90% of the company’s stock.

Luminex Corporation Company Profile

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company’s products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments.

Institutional Ownership by Quarter for Luminex Corporation (NASDAQ:LMNX)

Receive News & Stock Ratings for Luminex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corporation and related stocks with our FREE daily email newsletter.